RASAL1 Attenuates Gastric Carcinogenesis in Nude Mice by Blocking RAS/ERK Signaling |
Chen, Hong
(Department of Gastroenterology, Affiliated Zhongda Hospital, Southeast University)
Zhao, Ji-Yi (Department of Gastroenterology, Affiliated Zhongda Hospital, Southeast University) Qian, Xu-Chen (Department of Gastroenterology, Affiliated Zhongda Hospital, Southeast University) Cheng, Zheng-Yuan (Department of Gastroenterology, Jiangbei Hospital) Liu, Yang (Department of Gastroenterology, Affiliated Zhongda Hospital, Southeast University) Wang, Zhi (Department of Gastroenterology, Affiliated Zhongda Hospital, Southeast University) |
1 | Calvisi D F, Ladu S, Conner E A, et al (2011). Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol, 54, 311-9. DOI ScienceOn |
2 | Chen H, Cheng Z Y, Pan Y, et al (2014). RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway. Human cell, 27, 1-8. DOI |
3 | Chen H, Pan Y, Cheng ZY, et al (2013). Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Asian Pac J Cancer Prev, 14, 6261-5. DOI |
4 | Chen H, Yang XW, Zhang H, et al (2012). In vivo and In vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance. Oncology letters, 3, 535-40. |
5 | Cherfils J, Zeghouf M, (2013). Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiological reviews, 93, 269-309. DOI |
6 | Dote H, Toyooka S, Tsukuda K, et al (2005). Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br J Cancer, 92, 1117-25. DOI |
7 | Downward J (2003). Targeting RAS signalling pathways in cancer therapy. Nature Reviews Cancer, 3, 11-22. DOI |
8 | Jin SH, Akiyama Y, Fukamachi H, et al (2008). IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int J Cancer, 122, 1040-6. |
9 | Karnoub A E, Weinberg R A (2008). Ras oncogenes: split personalities. Nature Rev Molec Cell Biol, 9, 517-31. DOI |
10 | Liu D, Yang C, Bojdani E, et al (2013). Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer. J Natl Cancer Inst, 105, 1617-27. DOI |
11 | Liu J, Huang XE, Feng JF (2014).Further study on pemetrexed based chemotherapy in treating patients with advanced gastric cancer (AGC). Asian Pac J Cancer Prev, 15, 6587-90. DOI |
12 | Lu Q, Nassar N, Wang J. A mechanism of catalyzed GTP hydrolysis by Ras protein through magnesiumion. Chemical Physics Letters, 516, 233-8. |
13 | Maertens O, Cichowski K (2014). An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer. Adv Biological Regulation, 55, 1-14. DOI |
14 | Malumbres M, Barbacid M (2003). RAS oncogenes: the first 30 years. Nature Reviews Cancer, 3, 459-65. DOI |
15 | McLaughlin S K, Olsen S N, Dake B, et al (2013). The RasGAP Gene,RASAL2, is a tumor and metastasis suppressor. Cancer Cell, 24, 365-78. DOI |
16 | Qiao F, Su X, Qiu X, et al (2012). Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. Oncology Reports, 28, 1475-81. |
17 | Seto M, Ohta M, Ikenoue T, et al (2011). Reduced expression of RAS protein activator like-1 in gastric cancer. Int J Cancer, 128, 1293-302. DOI ScienceOn |
18 | Takemoto H, Doki Y, Shiozaki H, et al (2001). Localization of IQGAP1 is inversely correlated with intercellular adhesion mediated by E-cadherin in gastric cancers. Int J Cancer, 91, 783-8. DOI |
19 | Stephen A G, Esposito D, Bagni R K, et al (2014). Dragging Ras back in the ring. Cancer Cell, 25, 272-81. DOI |
20 | Sugimoto N, Imoto I, Fukuda Y, et al (2001). IQGAP1, a negative regulator of cell-cell adhesion, is upregulated by gene amplification at 15q26 in gastric cancer cell lines HSC39 and 40A. J Human Genetics, 46, 21-5. DOI |
21 | Walch A, Seidl S, Hermannstädter C, et al (2008). Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer. Modern Pathology, 21, 544-52. DOI ScienceOn |
22 | Wei GL, Huang XE, Huo JG, et al (2014).Phase II study on pemetrexed-based chemotherapy in treating patients with metastatic gastric cancer not responding to prior palliative chemotherapy. Asian Pac J Cancer Prev, 14, 2703-6. |
23 | Xu S, Zhou Y, Du WD, et al (2013). Association of the variant rs2243421 of human DOC-2/DAB2 interactive protein gene (hDAB2IP) with gastric cancer in the Chinese Han population. Gene, 515, 200-4. DOI |